Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021) Francisco Arrieta; Juan Pedro-Botet; Pedro Iglesias; Juan Carlos Obaya; Laura Montanez; Gonzalo Fernando Maldonado; Antonio Becerra; Jorge Navarro; J.C. Perez; Romina Petrecca; José Luis Pardo; Josep Ribalta; Víctor Sánchez-Margalet; Santiago Duran; Francisco Javier Tébar; Manuel Aguilar;

SEA 2024 Standards for Global Control of Vascular Risk José María Mostaza; Xavier Pintó; Pedro Armario; Luis Masana; José T. Real; Pedro Valdivielso; Teresa Arrobas-Velilla; Ramón Baeza-Trinidad; Pilar Calmarza; Jesús Cebollada; Miguel Civera-Andrés; José I. Cuende Melero; José L. Díaz-Díaz; Javier Espíldora-Hernández; Jacinto Fernández Pardo; Carlos Guijarro; Carles Jericó; Martín Laclaustra; Carlos Lahoz; José López-Miranda; Sergio Martínez-Hervás; Ovidio Muñiz-Grijalvo; José A. Páramo; Vicente Pascual; Juan Pedro-Botet; Pablo Pérez-Martínez; José Puzo;

Role of newer antidiabetic drugs on cardiovascular prevention and heart failure Jesús Miguel Rojas-Velázquez; Alejandro Giralt-Herrera; Jessica Leiva-Enríquez; Jennifer Leiva-Enríquez;